BE
NSE:BETA·Healthcare·Verified
BETA DRUGS LIMITED
₹2,090.50
-65.20(-3.02%)Day range₹2,076.70 – ₹2,205.00
52-week range₹990.10 – ₹2,250.00
Mkt Cap
2,110 Cr
P/E (TTM)
51.03
P/B
8.65
Div Yield
0.00%
Open / Prev
2,165.20 / 2,155.70
From 52W High
−7.09%
From 52W Low
+111.14%
Day Range
2,076.70–2,205.00
Preview · BETA
Preview the depth — unlock the full forensic study.
You're reading the free Overview. The full Landscape study, the Lenses, governance and quality scans unlock with Pro — across 5,000 Indian companies.
Briefing
BETA DRUGS LIMITED — the brief
BETA DRUGS LIMITED (BETA) trades on the NSE at ₹2,090.50 with a market capitalisation of 2,110 Cr. Classified under Healthcare · Drug Manufacturers - Specialty & Generic.
Forensic signal
From the company's own filingsSignal dossierBETA
1
Momentum
-3.02%2
52-Week
87% of range3
Valuation
P/E 51.0×4
Yield
0.00%5
Size
2,110 CrStrong: 52-Week · Weak: Momentum · Valuation · Yield · Size
87%
11%